Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-057863
Filing Date
2026-02-18
Accepted
2026-02-18 21:31:11
Documents
1
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7785
  Complete submission text file 0001193125-26-057863.txt   9370
Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Howton David T (Reporting) CIK: 0001529297 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38360 | Film No.: 26651333

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)